Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; and Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):418-425. doi: 10.1182/asheducation-2018.1.418.
Development of exercise guidelines for individuals with sickle cell trait (SCT) and sickle cell anemia (SCA) is hampered by the need to weigh the benefits against risks of exercise in these populations. In SCT, concern for exercise collapse associated with sickle cell trait has resulted in controversial screening of student athletes for SCT. In SCA, there exists unsubstantiated concerns that high-intensity exercise may result in pain and other complications. In both, finding the "right dose" of exercise remains a challenge for patients and their providers. Despite assumptions that factors predisposing to adverse events from high-intensity exercise overlap in SCT and SCA, the issues that frame our understanding of exercise-related harms in both are distinct. This review will compare issues that affect the risk-benefit balance of exercise in SCT and SCA through these key questions: (1) What is the evidence that high-intensity exercise is associated with harm? (2) What are the pathophysiologic mechanisms that could predispose to harm? (3) What are the preventive strategies that may reduce risk? and (4) Why do we need to consider the benefits of exercise in this debate? Addressing these knowledge gaps is essential for developing an evidence-based exercise prescription for these patient populations.
制定针对镰状细胞特质(SCT)和镰状细胞贫血(SCA)个体的运动指南受到限制,因为需要权衡这些人群运动的益处和风险。在 SCT 中,人们担心与 SCT 相关的运动性衰竭,这导致了对学生运动员进行 SCT 的有争议的筛查。在 SCA 中,存在未经证实的担忧,即高强度运动可能导致疼痛和其他并发症。在这两种情况下,为患者及其提供者找到“适当的运动量”仍然是一个挑战。尽管人们假设导致高强度运动不良事件的因素在 SCT 和 SCA 中重叠,但构成我们对这两种疾病与运动相关伤害的理解的问题是不同的。本综述将通过以下关键问题比较影响 SCT 和 SCA 中运动利弊平衡的问题:(1)高强度运动与伤害相关的证据是什么?(2)可能导致伤害的病理生理机制是什么?(3)哪些预防策略可能降低风险?以及(4)为什么我们需要在这场辩论中考虑运动的益处?解决这些知识空白对于为这些患者群体制定基于证据的运动处方至关重要。